BOSTON–(BUSINESS WIRE)–Elucid Bioimaging Inc. (“Elucid Bio”) today announced that vascuCAP, Elucid Bio’s AI-enabled software for evaluating atherosclerotic plaque stability from CTA, has been added to the IBM Imaging AI Marketplace, an IBM Watson Health® solution. The IBM Imaging AI Marketplace provides streamlined access to meaningful AI technologies designed to support leaders […]
Other News
Teleflex Named One of America’s Best-In-State Employers 2020 by Forbes
Company ranks as a top employer in the state of Pennsylvania where its corporate headquarters are located WAYNE, Pa., Oct. 08, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ annual list of America’s Best-In-State Employers 2020. The company ranked #6 out of 100 […]
CB Scientific, Inc. (CBSC) Announces the Launch of My-Cardia ECG Products and Services in Thailand
Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd. to begin exclusive distribution of CB Scientific’s FDA & CE-cleared EKG products to an expansive private and government hospital network ESCONDIDO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) — via Network Wire — CB Scientific. Inc. (OTC:CBSC) (“CBSC” or the “Company”), […]
Butterfly Network and American College of Cardiology Join Forces to Transform Cardiovascular Care with Ultrasound
Butterfly Network forms a landmark collaboration with the American College of Cardiology to revolutionize cardiovascular care using innovative point-of-care ultrasound imaging. GUILFORD, Conn., Oct. 8, 2020 /PRNewswire/ — Butterfly Network and the American College of Cardiology (ACC) are joining forces to transform the use of ultrasound within cardiology using the Butterfly iQ+. Earlier this […]
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Trial Met Primary Composite Endpoint of Reduction in Cardiovascular Death or Heart Failure Events Trial Did Not Meet Secondary Endpoint of Reduction in Cardiovascular Death Results Will Be Presented in Late Breaking Clinical Trial Session at AHA Scientific Sessions 2020 THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Oct. 8, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN), Cytokinetics, […]
First Patients Treated with Galaxy Medical’s Centauri™ Pulsed Electric Field Cardiac Ablation System
SAN CARLOS, Calif., Oct. 8, 2020 /PRNewswire/ — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients in the ECLIPSE-AF study were successfully treated with the proprietary Centauri™ System by Dr. Ante Anić in Split, Croatia. This multicenter trial is designed […]
R3 Vascular Inc. Completes Series A Financing
$17.8 million in proceeds will fund clinical development of innovative devices to treat peripheral artery diseases (PAD) such as CLI MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–R3 Vascular Inc. today announced closing of its Series A financing round, including new equity investments of $15 million and the conversion of $2.8 million of convertible notes. […]
Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy will be released at TCT Connect 2020. Severe calcification […]
Rick Anderson and Mark Toland Join Cardiologs’ Board of Directors
Visionary leaders with proven experience commercializing technologies around the globe bring strategic insight to the company’s board of directors to accelerate growth and innovation PARIS and BOSTON, Oct. 7, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, announced today that it has appointed two veteran medical device industry executives […]
CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced data from a retrospective study and a case study supporting the benefit of Aquadex™ therapy in the treatment of heart […]
Recent
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
Popular
- No commented posts yet